Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... Report on Form 10-K filed with the Securities and
exchange Commission on March 6, 2009, the company's ... March 31, 2009 filed with the Securities and
exchange Commission on May 8, 2009, and the company's ... ----- -----
Effect of
exchange rates on cash and cash
equivalents ...
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
... global economic conditions; interest and currency
exchange rate fluctuations and volatility in the credit ... periodic reports filed with the Securities and
exchange Commission, including our current reports on Form ... 31, 2008, which was filed with the Securities and
exchange Commission on February 27, 2009. The ...
Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
... informal investigation by the U.S. Securities and
exchange Commission into Foreign Corrupt Practices Act ... conditions, including interest rate and currency
exchange rate fluctuations; and the costs of defending or ... reports filed with the U.S. Securities and
exchange Commission. We disclaim any intention or ...
New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
... Act of 1933 and Section 21E of the Securities
exchange Act of 1934, in connection with the Private ... April 4, 2009, filed with the Securities and
exchange Commission (" SEC ") on May 6, 2009, which may be ... April 4, 2009, filed with the Securities and
exchange Commission (" SEC ") on May 6, 2009, whether as a ...
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
... global economic conditions; interest and currency
exchange rate fluctuations and volatility in the credit ... periodic reports filed with the Securities and
exchange Commission, including our current reports on Form ... 31, 2008, which was filed with the Securities and
exchange Commission on February 27, 2009. The ...
Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
... protocol regionally for the past four years to
exchange millions of transactions in our market. With the ... offered a solution to make health information
exchange as easy as email," said John Kelly, Director for ... neutral. Therefore participants are able to
exchange data with any technology and applications they ...
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... conditions, such as interest rate and currency
exchange rate fluctuations; technological advances and ... periodic reports filed with the Securities and
exchange Commission, including our current reports on Form ... 31, 2007, which was filed with the Securities and
exchange Commission on April 29, 2008. The forward-looking ...
Pharmaxis Announces New Drug Application Submission for Aridol(TM)
... Pharmaxis is listed on the Australian Securities
exchange (symbol PXS), and on NASDAQ Global Market (symbol ... the meaning of Section 21E of the Securities
exchange Act of 1934, as amended. Forward-looking ... our Form 20-F lodged with the U.S. Securities and
exchange Commission.
...
Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology
... informal investigation by the U.S. Securities and
exchange Commission into Foreign Corrupt Practices Act ... conditions, including interest rate and currency
exchange rate fluctuations; and the costs of defending or ... reports filed with the U.S. Securities and
exchange Commission. We disclaim any intention or ...
Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
... been accepted for trading on the Frankfurt Stock
exchange under the ticker symbol "0IM". The International ... number is US45257K1007. The Frankfurt Stock
exchange (FWB) is one of the world's largest trading ... trading volume in Germany. The Frankfurt Stock
exchange facilitates advanced electronic trading, ...
Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
... conditions, such as interest rate and currency
exchange rate fluctuations; technological advances and ... periodic reports filed with the Securities and
exchange Commission, including our current reports on Form ... 31, 2007, which was filed with the Securities and
exchange Commission on April 29, 2008. The forward-looking ...
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
... conditions, such as interest rate and currency
exchange rate fluctuations; technological advances and ... periodic reports filed with the Securities and
exchange Commission, including our current reports on Form ... 31, 2007, which was filed with the Securities and
exchange Commission on April 29, 2008. The forward-looking ...
Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
... Reuters shares are listed on
the New York Stock
exchange (NYSE: TRI ); Toronto Stock
exchange (TSX: TRI);
London Stock
exchange (LSE: TRIL); and Nasdaq (Nasdaq: TRIN ). For ...
Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
... including interest and currency
exchange rate fluctuations; changes
in generally accepted ... periodic reports filed with the
Securities and
exchange Commission, including our current reports on Form ... 31, 2007, which was filed with the
Securities and
exchange Commission on February 29, 2008. The ...
Micromet Expands Committed Equity Financing Facility to $75 Million
... as follows:
-- After the Securities and
exchange Commission (SEC) declares effective the ... from Kingsbridge through December 1, 2011, in
exchange for newly-issued shares of Micromet's common ... as amended, and Section 21E of the Securities
exchange Act of 1934, as amended, and, as such, speak only ...
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
... shares and the
contingent value rights."
Share
exchange information and a letter of transmittal will be ... have any questions, please contact
ViroPharma's
exchange agent, StockTrans, at (800) 733-1121.
... on Form 10-Q filed with the Securities and
exchange Commission
during 2008, could cause future ...
Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
... system that connects to Alsius'
proprietary heat
exchange catheters. The catheters are inserted into ... in Alsius' filings
with the Securities and
exchange Commission, which can be accessed
electronically on the Securities and
exchange Commission website at
http://www.sec.gov .
...
Genzyme and Isis Complete Licensing of Mipomersen
... will end
when the program is profitable. In
exchange for this additional
contribution, Isis has the ... will end
when the program is profitable. In
exchange for this additional
contribution, Isis has the ... Genzyme's SEC reports filed
under the Securities
exchange Act of 1934, including the factors ...
Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine
... March 31, 2008, and filed with the
Securities and
exchange Commission. Iomai cautions investors and others ... the Company files
with the U.S. Securities and
exchange Commission, available at
http://www.sec.gov . ... for its stockholders with
the Securities and
exchange Commission (SEC). Iomai Corporation will ...
New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
... 31, 2007 as filed
with the Securities and
exchange Commission. Synta undertakes no obligation
to ... 19:19-25.
(9) United States Securities and
exchange Commission. Synta
Pharmaceuticals Corp. Form ... Pursuant to Section 13 or
15(d) of the Securities
exchange Act of 1934. Commission file number
002-33277. ...
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
... to be
accomplished through stock-for-stock
exchange for approximately 41 percent of Iomai's current ... Iomai's outstanding
common stock, have agreed to
exchange their shares for Intercell stock at
an
exchange ratio corresponding to a value of USD 6.60 per ...
More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
... conditions including
interest and currency
exchange rate fluctuations; changes in generally
accepted ... periodic reports filed
with the Securities and
exchange Commission, including our current reports
on Form ... 31, 2007, which
was filed with the Securities and
exchange Commission on February 29, 2008.
The ...
Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
... first. Through the program,
the company will
exchange unopened, expired compounded ... program were
surprised and delighted that we will
exchange medications that were
compounded by other ... . Within 30 days after expiration they
can
exchange medications that meet the program's criteria by ...
CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
... AND SECTION 21E OF THE UNITED STATES SECURITIES
exchange ACT OF
1934, AS AMENDED. STATEMENTS IN THIS NEWS ... WITH
THE CLOSING OF THE CLOSING OF THE SHARE
exchange AGREEMENT AND THE
DEVELOPMENT AND FUNDING OF THE ... WITH THE UNITED STATES SECURITIES
AND
exchange COMMISSION. THIS NEWS RELEASE HAS BEEN PREPARED ...
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
... and in the company's various filings with the Securities and
exchange Commission.
Forward Looking Statements
Statements herein ... operations, is contained in Novavax's filings with the U.S. Securities and
exchange Commission, which are available at www.sec.gov . These ...
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
... 10-Q for the period ended March 31, 2009 filed with the Securities and
exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and
exchange Commission.
...
Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
... granting Eli Lilly and Company exclusive worldwide rights to dirucotide in
exchange for an upfront payment, milestone payments and escalating royalties on ... see Lilly's filings with the United States Securities and
exchange Commission and BioMS' filings with SEDAR. We undertake no obligation to ...
Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
... and any other risk factors described in our filing with the Securities and
exchange Commission. The foregoing list is not exhaustive, and the Company ... documents the Company files from time to time with the Securities and
exchange Commission, including the most recent Annual Report on Form 10-KSB, ...
Cyberonics Provides Update on Depression Post-Approval Study
... the Securities Act of 1933, as amended and Section 21E of the Securities
exchange Act of 1934, as amended. These statements can be identified by the use of ... risks detailed from time to time in our filings with the Securities and
exchange Commission (SEC). For a detailed discussion of these and other cautionary ...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
... the Securities Act of 1933, as amended, and Section 21E of the Securities
exchange Act of 1934, as amended. The forward-looking statements are based on Human ... and other risks described in the Company's filings with the Securities and
exchange Commission. In addition, while the Company has completed delivery of ...
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... from time to time in our periodic reports filed with the Securities and
exchange Commission, including our current reports on Form 8-K, quarterly reports ... the year ended December 31, 2008, which was filed with the Securities and
exchange Commission on March 2, 2009. The forward-looking statements in this press ...
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
... detailed in the NovaBay's and Alcon's filings with the Securities and
exchange Commission. Given these uncertainties, you should not place undue ... laws and the rules and regulations promulgated by the Securities and
exchange Commission, we undertake no obligation to publicly update or revise any of ...
More Gene Mutations Linked to Autism Risk
... Chair of the Steering committee for Autism Speaks' Autism Genetic Resource
exchange (AGRE). "We are grateful to families of children with autism spectrum ... and medical programs. To learn more about the Autism Genome Resource
exchange (AGRE), please visit ...